Voyager Therapeutics Inc (VYGR) Price Prediction & ForecastVYGRVoyager Therapeutics Inc

Alphio's VYGR stock price prediction model matches the current Voyager Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.72 (+0.09%). The 1-week path is $1.71 (-0.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Voyager Therapeutics Inc (VYGR) is currently trading at $1.78, which is close to its 52-week low of $1.68. The stock has seen a significant decline of 55.83% year-to-date, indicating a challenging market environment. The RSI is at 39.49, suggesting that the stock is nearing oversold territory, which could indicate a potential reversal in price. However, the forward P/E ratio is 8.44, which is relatively low compared to industry standards, hinting at potential undervaluation. The main risk is the negative net income, which was reported at -$27.9 million for Q1 2026, indicating ongoing financial struggles. Therefore, while there are some indicators of potential recovery, the overall financial performance and recent price history suggest that it may be prudent to hold rather than buy at this time.

Voyager Therapeutics Inc (VYGR) last closed at $1.72, losing -8.02%. These facts feed the 1-day and 1-week VYGR price prediction above.